Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.

Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Koyama T, Penson DF
Cancer. 2014 120 (8): 1263-71

PMID: 24510400 · PMCID: PMC4930672 · DOI:10.1002/cncr.28563

MeSH Terms (16)

Aged Age Factors Cohort Studies Comorbidity Erectile Dysfunction Hormones Humans Intestinal Diseases Linear Models Male Middle Aged Prevalence Prospective Studies Prostatic Neoplasms Risk Factors Urinary Incontinence

Connections (3)

This publication is referenced by other Labnodes entities: